Related references
Note: Only part of the references are listed.Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma
Huayu Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
Yunfan Sun et al.
CELL (2021)
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy
Rajasekharan Somasundaram et al.
NATURE COMMUNICATIONS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
Hao Xu et al.
BIOENGINEERED (2021)
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
Yichao Wu et al.
CANCER COMMUNICATIONS (2020)
Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation
Jinchul Kim et al.
CANCER CELL (2019)
The International Cancer Genome Consortium Data Portal
Junjun Zhang et al.
NATURE BIOTECHNOLOGY (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Qiang Gao et al.
CELL (2019)
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J. Harding et al.
CLINICAL CANCER RESEARCH (2019)
Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC
Roser Pinyol et al.
CLINICAL CANCER RESEARCH (2019)
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo A. Knijnenburg et al.
CELL REPORTS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Vaccines targeting helper T cells for cancer immunotherapy
Marit Meissen et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization
Taosheng Xu et al.
BIOINFORMATICS (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
Erica Villa et al.
GUT (2016)
Mechanics and Single-Molecule Interrogation of DNA Recombination
Jason C. Bell et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
DNA repair, genome stability and cancer: a historical perspective
Penny A. Jeggo et al.
NATURE REVIEWS CANCER (2016)
An update on PARP inhibitors-moving to the adjuvant setting
Amir Sonnenblick et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Therapeutic opportunities within the DNA damage response
Laurence H. Pearl et al.
NATURE REVIEWS CANCER (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)